First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label,... von Paz-Ares, Luis, Ciuleanu, Tudor-Eliade, Cobo, Manuel, Schenker, Michael, Zurawski, Bogdan, Menezes, Juliana, Richardet, Eduardo, Bennouna, Jaafar, Felip, Enriqueta, Juan-Vidal, Oscar, Alexandru, Aurelia, Sakai, Hiroshi, Lingua, Alejo, Salman, Pamela, Souquet, Pierre-Jean, De Marchi, Pedro, Martin, Claudio, Pérol, Maurice, Scherpereel, Arnaud, Lu, Shun, John, Thomas, Carbone, David P, Meadows-Shropshire, Stephanie, Agrawal, Shruti, Oukessou, Abderrahim, Yan, Jinchun, Reck, Martin

Volltext

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizu... von Tabernero, Josep, Dr, Yoshino, Takayuki, MD, Cohn, Allen Lee, MD, Obermannova, Radka, MD, Bodoky, Gyorgy, Prof, Garcia-Carbonero, Rocio, MD, Ciuleanu, Tudor-Eliade, Prof, Portnoy, David C, MD, Van Cutsem, Eric, Prof, Grothey, Axel, MD, Prausová, Jana, MD, Garcia-Alfonso, Pilar, PhD, Yamazaki, Kentaro, MD, Clingan, Philip R, Prof, Lonardi, Sara, MD, Kim, Tae Won, Prof, Simms, Lorinda, MS, Chang, Shao-Chun, PhD, Nasroulah, Federico, MD

Volltext

Perioperative Nivolumab in Resectable Lung Cancer von Cascone, Tina, Awad, Mark M., Spicer, Jonathan D., He, Jie, Lu, Shun, Sepesi, Boris, Tanaka, Fumihiro, Taube, Janis M., Cornelissen, Robin, Havel, Libor, Karaseva, Nina, Kuzdzal, Jaroslaw, Petruzelka, Lubos B., Wu, Lin, Pujol, Jean-Louis, Ito, Hiroyuki, Ciuleanu, Tudor-Eliade, de Oliveira Muniz Koch, Ludmila, Janssens, Annelies, Alexandru, Aurelia, Bohnet, Sabine, Moiseyenko, Fedor V., Gao, Yang, Watanabe, Yasutaka, Coronado Erdmann, Cinthya, Sathyanarayana, Padma, Meadows-Shropshire, Stephanie, Blum, Steven I., Provencio Pulla, Mariano

Volltext

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL... von Garon, Edward B, Dr, Ciuleanu, Tudor-Eliade, Prof, Arrieta, Oscar, MD, Prabhash, Kumar, Prof, Syrigos, Konstantinos N, Prof, Goksel, Tuncay, Prof, Park, Keunchil, Prof, Gorbunova, Vera, MD, Kowalyszyn, Ruben Dario, MD, Pikiel, Joanna, MD, Czyzewicz, Grzegorz, MD, Orlov, Sergey V, Prof, Lewanski, Conrad R, MD, Thomas, Michael, Prof, Bidoli, Paolo, MD, Dakhil, Shaker, MD, Gans, Steven, MD, Kim, Joo-Hang, Prof, Grigorescu, Alexandru, Prof, Karaseva, Nina, MD, Reck, Martin, MD, Cappuzzo, Federico, MD, Alexandris, Ekaterine, MS, Sashegyi, Andreas, PhD, Yurasov, Sergey, MD, Pérol, Maurice, MD

Volltext

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial von Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof

Volltext

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic C... von PEETERS, Marc, JAY PRICE, Timothy, STRICKLAND, Andrew H, WILSON, Gregory, CIULEANU, Tudor-Eliade, ROMAN, Laslo, VAN CUTSEM, Eric, TZEKOVA, Valentina, COLLINS, Simon, OLINER, Kelly S, RONG, Alan, GANSERT, Jennifer, CERVANTES, Andrés, SOBRERO, Alberto F, DUCREUX, Michel, HOTKO, Yevhen, ANDRE, Thierry, CHAN, Emily, LORDICK, Florian, PUNT, Cornelis J. A

Volltext

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial... von RAMLAU, Rodryg, GORBUNOVA, Vera, REY, Augustin, MILLER, Vincent, THATCHER, Nicholas, SCAGLIOTTI, Giorgio, ELIADE CIULEANU, Tudor, NOVELLO, Silvia, OZGUROGLU, Mustafa, GOKSEL, Tuncay, BALDOTTO, Clarissa, BENNOUNA, Jaafar, SHEPHERD, Frances A, LE-GUENNEC, Solenn

Volltext

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer von O'BRIEN, Mary E. R, CIULEANU, Tudor-Eliade, TSEKOV, Hristo, SHPARYK, Yaroslav, CUCEVIA, Branka, JUHASZ, Gabor, THATCHER, Nicholas, ROSS, Graham A, DANE, Graham C, CROFTS, Theresa

Volltext

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Stu... von GOSS, Glenwood D, ARNOLD, Andrew, ELLIS, Peter M, LAURIE, Scott A, DING, Keyue, FRYMIRE, Eliot, GAUTHIER, Isabelle, LEIGHL, Natasha B, HO, Cheryl, NOBLE, Jonathan, LEE, Christopher W, SEYMOUR, Lesley, SHEPHERD, Frances A, DEDIU, Mircea, CIULEANU, Tudor-Eliade, FENTON, David, ZUKIN, Mauro, WALDE, David, LABERGE, Francis, VINCENT, Mark D

Volltext

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy von Iluta, Sabina, Pasca, Sergiu, Gafencu, Grigore, Jurj, Ancuta, Terec, Andreea, Teodorescu, Patric, Selicean, Cristina, Jitaru, Ciprian, Preda, Alexandra, Cenariu, Diana, Constantinescu, Catalin, Iordache, Maria, Tigu, Bogdan, Munteanu, Raluca, Feder, Richard, Dima, Delia, Zdrenghea, Mihnea, Gulei, Diana, Ciuleanu, Tudor-Eliade, Tomuleasa, Ciprian

Volltext

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the Che... von Carbone, David P., Ciuleanu, Tudor-Eliade, Schenker, Michael, Cobo, Manuel, Bordenave, Stéphanie, Juan-Vidal, Oscar, Menezes, Juliana, Reinmuth, Niels, Richardet, Eduardo, Cheng, Ying, Mizutani, Hideaki, Felip, Enriqueta, Zurawski, Bogdan, Alexandru, Aurelia, Paz-Ares, Luis, Lu, Shun, John, Thomas, Zhang, Xiaoqing, Mahmood, Javed, Hu, Nan, De, Tuli, Santi, Irene, Penrod, John R., Yuan, Yong, Lee, Adam, Reck, Martin

Volltext

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer von Forde, Patrick M, Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M, Felip, Enriqueta, Broderick, Stephen R, Brahmer, Julie R, Swanson, Scott J, Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B, Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke Neng, Liberman, Moishe, Vokes, Everett E, Taube, Janis M, Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y, Girard, Nicolas

Volltext

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer von Forde, Patrick M., Spicer, Jonathan, Lu, Shun, Provencio, Mariano, Mitsudomi, Tetsuya, Awad, Mark M., Felip, Enriqueta, Broderick, Stephen R., Brahmer, Julie R., Swanson, Scott J., Kerr, Keith, Wang, Changli, Ciuleanu, Tudor-Eliade, Saylors, Gene B., Tanaka, Fumihiro, Ito, Hiroyuki, Chen, Ke-Neng, Liberman, Moishe, Vokes, Everett E., Taube, Janis M., Dorange, Cecile, Cai, Junliang, Fiore, Joseph, Jarkowski, Anthony, Balli, David, Sausen, Mark, Pandya, Dimple, Calvet, Christophe Y., Girard, Nicolas

Volltext

Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia von Auerbach, Michael, Silberstein, Peter T., Webb, R. Timothy, Averyanova, Svetlana, Ciuleanu, Tudor‐Eliade, Shao, James, Bridges, Kenneth

Volltext

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227 von Brahmer, Julie R, Lee, Jong-Seok, Ciuleanu, Tudor-Eliade, Bernabe Caro, Reyes, Nishio, Makoto, Urban, Laszlo, Audigier-Valette, Clarisse, Lupinacci, Lorena, Sangha, Randeep, Pluzanski, Adam, Burgers, Jacobus, Mahave, Mauricio, Ahmed, Samreen, Schoenfeld, Adam J, Paz-Ares, Luis G, Reck, Martin, Borghaei, Hossein, O'Byrne, Kenneth J, Gupta, Ravi G, Bushong, Judith, Li, Li, Blum, Steven I, Eccles, Laura J, Ramalingam, Suresh S

Volltext

Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours von Radulescu, Liliana Maria, Radulescu, Dan, Ciuleanu, Tudor-Eliade, Crisan, Dana, Buzdugan, Elena, Romitan, Dragos-Mihai, Buzoianu, Anca Dana

Volltext

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial von Paz-Ares, Luis G., Ramalingam, Suresh S., Ciuleanu, Tudor-Eliade, Lee, Jong-Seok, Urban, Laszlo, Caro, Reyes Bernabe, Park, Keunchil, Sakai, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Audigier-Valette, Clarisse, Burgers, Jacobus A., Pluzanski, Adam, Sangha, Randeep, Gallardo, Carlos, Takeda, Masayuki, Linardou, Helena, Lupinacci, Lorena, Lee, Ki Hyeong, Caserta, Claudia, Provencio, Mariano, Carcereny, Enric, Otterson, Gregory A., Schenker, Michael, Zurawski, Bogdan, Alexandru, Aurelia, Vergnenegre, Alain, Raimbourg, Judith, Feeney, Kynan, Kim, Sang-We, Borghaei, Hossein, O'Byrne, Kenneth John, Hellmann, Matthew D., Memaj, Arteid, Nathan, Faith Ellen, Bushong, Judith, Tran, Phuong, Brahmer, Julie R., Reck, Martin

Volltext

Cardiomyopathies and Arrhythmias Induced by Cancer Therapies von Romitan, Dragoș-Mihai, Rădulescu, Dan, Berindan-Neagoe, Ioana, Stoicescu, Laurențiu, Grosu, Alin, Rădulescu, Liliana, Gulei, Diana, Ciuleanu, Tudor-Eliade

Volltext

First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain M... von Paz-Ares, Luis G., Ciuleanu, Tudor-Eliade, Cobo, Manuel, Bennouna, Jaafar, Schenker, Michael, Cheng, Ying, Juan-Vidal, Oscar, Mizutani, Hideaki, Lingua, Alejo, Reyes-Cosmelli, Felipe, Reinmuth, Niels, Menezes, Juliana, Jassem, Jacek, Protsenko, Svetlana, Richardet, Eduardo, Felip, Enriqueta, Feeney, Kynan, Zurawski, Bogdan, Alexandru, Aurelia, de la Mora Jimenez, Emmanuel, Dakhil, Shaker, Lu, Shun, Reck, Martin, John, Thomas, Hu, Nan, Zhang, Xiaoqing, Sylvester, Judi, Eccles, Laura J., Grootendorst, Diederik J., Balli, David, Neely, Jaclyn, Carbone, David P.

Volltext